A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection is a research paper published in Journal of Virus Eradication (2020). On theSindex it has a DataRank of 0.571. It has been cited 44 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.571
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCATS NIH HHS
Grant: UL1 TR001863
NIAID NIH HHS
Grant: R01 AI108433
National Health and Medical Research Council (NHMRC)
Grant: 1052979
HIV latency, pathogenesis and immunity
National Institutes of Health
Grant: 7R01AI108433-03
Preservation of adaptive immunity leads to HIV control upon treatment cessation.
National Institutes of Health
Grant: 1R01NS084911-01
Therapeutic Interventions during Acute Infection to Address the CNS Reservoir for
National Institute of Allergy and Infectious Diseases
Delaney AIDS Research Enterprise
National Cancer Institute
National Health and Medical Research Council
National Institute of Neurological Disorders and Stroke
FWCI
0.63
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals